Cash Flow

v3.8.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Cash Flows From Operating Activities:    
Net loss $ (3,246,166) $ (2,175,898)
Adjustments to reconcile net loss to net cash used in operating activities:    
Gain on revaluation of derivative warrant liability (622,186)
Stock-based compensation expense 290,021 241,514
Issuance of common stock for release agreement 257,400
Depreciation 642 672
Changes in operating assets and liabilities:    
Prepaid expenses 109,429 154,958
Accounts payable (41,271) 76,709
Accrued expenses 55,295 888,961
Accrued compensation 140,376 107,250
Accrued interest, related parties 3,192 13,228
Due to related party (10,000)
Net Cash Used In Operating Activities (2,441,082) (1,314,792)
Cash Flows From Financing Activities:    
Proceeds from notes payable - related parties 820,000
Proceeds from common stock warrant exercises 1,125,148
Net proceeds from registered direct offering 5,482,523
Net proceeds from private placements 247,205
Net Cash Provided By Financing Activities 6,607,671 1,067,205
Net Change in Cash and Cash Equivalents 4,166,589 (247,587)
Cash and Cash Equivalents - Beginning of Period 3,204,108 294,351
Cash and Cash Equivalents - End of Period 7,370,697 46,764
Supplemental Disclosures Of Cash Flow Information and Non-cash Transactions:    
Interest paid 192
Reclassification of derivative warrant liability to additional paid-in capital 149,209
Par value of common stock issued upon cashless exercise of warrants $ 17

Source